Literature DB >> 23575040

Complete remission of severe chronic recurrent angioedema of unknown cause with omalizumab.

Antonie von Websky, Kristian Reich, Volker Steinkraus, Kristine Breuer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23575040     DOI: 10.1111/ddg.12075

Source DB:  PubMed          Journal:  J Dtsch Dermatol Ges        ISSN: 1610-0379            Impact factor:   5.584


× No keyword cloud information.
  7 in total

Review 1.  Idiopathic Non-histaminergic Angioedema: Successful Treatment with Omalizumab in Five Patients.

Authors:  Charles Faisant; Aurélie Du Thanh; Catherine Mansard; Alban Deroux; Isabelle Boccon-Gibod; Laurence Bouillet
Journal:  J Clin Immunol       Date:  2016-11-08       Impact factor: 8.317

Review 2.  Emerging Therapies in Hereditary Angioedema.

Authors:  Meng Chen; Marc A Riedl
Journal:  Immunol Allergy Clin North Am       Date:  2017-08       Impact factor: 3.479

3.  Efficacy of Omalizumab in a Patient with Angioedema Clinically Resembling a Hereditary Angioedema.

Authors:  Ali Kutlu; Ercan Karabacak; Ersin Aydın; Selim Akarsu; Sami Öztürk
Journal:  Ann Dermatol       Date:  2016-05-25       Impact factor: 1.444

4.  Omalizumab in recurring larynx angioedema: a case report.

Authors:  Ayse Bilge Ozturk; Emek Kocaturk
Journal:  Asia Pac Allergy       Date:  2014-04-29

5.  Idiopathic non-histaminergic acquired angioedema: a case series and discussion of published clinical trials.

Authors:  Martin Christian Bucher; Tatjana Petkovic; Arthur Helbling; Urs Christian Steiner
Journal:  Clin Transl Allergy       Date:  2017-08-31       Impact factor: 5.871

Review 6.  Efficacy of Treatment of Non-hereditary Angioedema.

Authors:  Mignon van den Elzen; M F C L Go; A C Knulst; M A Blankestijn; H van Os-Medendorp; H G Otten
Journal:  Clin Rev Allergy Immunol       Date:  2018-06       Impact factor: 8.667

7.  Omalizumab for Idiopathic Nonhistaminergic Angioedema: Evidence for Efficacy in 2 Patients.

Authors:  Enrico Brunetta; Dana Shiffer; Marco Folci; Maria I S Achenza; Francesca Puggioni; Enrico Heffler; Raffaello Furlan; Giorgio W Canonica
Journal:  Case Reports Immunol       Date:  2018-07-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.